Skip to main content
Equibles

Trexquant Investment LP

Position in REPL — Replimune Group, Inc.

CIK 1633445 STAMFORD, CT
Back to REPL Full portfolio

Position in REPL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,422,528
-$331,873 QoQ
Shares Held
128,503
-28.8% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#54
of 199 holders
Holding Since
Dec 2020
15 quarters on record
Voting authority Sole 91% Shared 0% None 9%

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Trexquant Investment LP holds $612,941,942 across 144 Biotechnology names. REPL ranks #96 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MRNA
Moderna, Inc.
 505,160 $35,376,354
2 TWST
Twist Bioscience Corp
 255,271 $26,262,280
3 REGN
Regeneron Pharmaceuticals, Inc.
 41,839 $26,088,290
4 RVMD
Revolution Medicines, Inc.
 120,122 $22,496,448
5 AXSM
Axsome Therapeutics, Inc.
 83,679 $20,482,108
6 RARE
Ultragenyx Pharmaceutical Inc.
 556,385 $18,577,695
7 INSM
INSMED Inc
 156,553 $16,691,680
8 SRRK
Scholar Rock Holding Corp
 275,712 $15,164,160

All Filings in REPL

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,422,528 128,503
2025-12-31 $1,754,401 180,494
2025-06-30 $1,221,495 131,485
2025-03-31 $1,487,226 152,536
2024-12-31 $2,356,509 194,592
2024-09-30 $2,920,522 266,471
2024-06-30 $550,782 61,198
2024-03-31 $820,545 100,434
2023-06-30 $587,419 25,298
2023-03-31 $1,664,172 94,234
2022-12-31 $878,478 32,297
2022-09-30 $390,716 22,624
2022-06-30 $319,744 18,292
2022-03-31 $570,273 33,585
2020-12-31 $373,717 9,796